Standpoint Raised Its FY10 Price Target on Pfizer (PFE) to $24

Standpoint Raised Its FY10 Price Target on Pfizer (PFE) to $24
StreetInsider.com - 2 hours ago
Standpoint Research raised its price target on Pfizer (NYSE: PFE) for 2010 and 2011 to $24 and $28 respectively, while reiterating their Buy rating. The firm said PFE has lagged the sector and ...
Pfizer’s Price Target Raised, “Buy†Rating Reiterated at Standpoint Research (PFE) - NASDAQ
Pfizer's Price Target Raised, “Buy” Rating Reiterated at Standpoint Research (PFE) - Dividend.com